1. Home
  2. STCN vs ARMP Comparison

STCN vs ARMP Comparison

Compare STCN & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STCN
  • ARMP
  • Stock Information
  • Founded
  • STCN 1986
  • ARMP N/A
  • Country
  • STCN United States
  • ARMP United States
  • Employees
  • STCN N/A
  • ARMP N/A
  • Industry
  • STCN Advertising
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • STCN Consumer Discretionary
  • ARMP Health Care
  • Exchange
  • STCN Nasdaq
  • ARMP Nasdaq
  • Market Cap
  • STCN 78.4M
  • ARMP 80.0M
  • IPO Year
  • STCN 1994
  • ARMP N/A
  • Fundamental
  • Price
  • STCN $12.48
  • ARMP $2.00
  • Analyst Decision
  • STCN
  • ARMP Strong Buy
  • Analyst Count
  • STCN 0
  • ARMP 1
  • Target Price
  • STCN N/A
  • ARMP $7.00
  • AVG Volume (30 Days)
  • STCN 23.1K
  • ARMP 9.2K
  • Earning Date
  • STCN 12-12-2024
  • ARMP 11-13-2024
  • Dividend Yield
  • STCN N/A
  • ARMP N/A
  • EPS Growth
  • STCN 358.74
  • ARMP N/A
  • EPS
  • STCN 3.04
  • ARMP N/A
  • Revenue
  • STCN $183,255,000.00
  • ARMP $5,467,000.00
  • Revenue This Year
  • STCN N/A
  • ARMP N/A
  • Revenue Next Year
  • STCN N/A
  • ARMP $83.33
  • P/E Ratio
  • STCN $4.07
  • ARMP N/A
  • Revenue Growth
  • STCN 2.34
  • ARMP 34.92
  • 52 Week Low
  • STCN $7.36
  • ARMP $1.97
  • 52 Week High
  • STCN $13.00
  • ARMP $4.48
  • Technical
  • Relative Strength Index (RSI)
  • STCN 67.87
  • ARMP 38.26
  • Support Level
  • STCN $12.00
  • ARMP $2.14
  • Resistance Level
  • STCN $12.76
  • ARMP $2.30
  • Average True Range (ATR)
  • STCN 0.35
  • ARMP 0.12
  • MACD
  • STCN 0.05
  • ARMP -0.02
  • Stochastic Oscillator
  • STCN 90.00
  • ARMP 6.98

About STCN Steel Connect Inc.

Steel Connect Inc is a diversified holding company. Through its subsidiary, the company provides digital and physical supply chain solutions to many brands across a diverse range of industries, including consumer electronics, telecommunications, computing and storage, software, and others. It also produces and licenses an entitlement management solution powered by its enterprise-class Poetic software, which offers a complete solution for activation, provisioning, entitlement subscription, and data collection from physical goods (connected products) and digital products. The group has an integrated network of facilities throughout North America, Europe, and Asia Pacific. Geographically, it derives key revenue from Mainland China and rest from the United States, Czech, and other regions.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

Share on Social Networks: